Placeholder Banner

BIO Announces GreenTech Investor Sessions at the 2018 World Congress in July

June 27, 2018

Washington, D.C. (June 27, 2018) – The Biotechnology Innovation Organization (BIO) today announced that nine emerging companies will make formal presentations to investors during GreenTech Investor Sessions at the 2018 BIO World Congress on Industrial Biotechnology. As part of GreenTech Investor Sessions, BIO will also host a panel discussion featuring representatives from investment firms to cover the most recent financial strategies and trends in industrial biotechnology. The world’s largest conference on industrial biotechnology and partnering event will be held July 16-19, 2018 at the Pennsylvania Convention Center in Philadelphia.

BIO’s GreenTech Investor Sessions provide high visibility to early stage emerging industrial biotechnology companies developing advanced biofuels and renewable chemical platforms to share their new technologies and value proposition through formal 15-minute presentations to an elite audience of investors and analysts. Companies were selected to present breakthrough technologies, bio-based consumer product strategies, proofs of concept, and extensive intellectual property coverage during this session.

The GreenTech Investor Sessions and panel will take place Tuesday, July 17. The panel discussion will take place 9:10 – 10 a.m. and will be moderated by Roger Wyse, PhD, managing partner at Spruce Capital Partners. Panelists include:

GreenTech Investor Sessions will take place starting at 8:30 a.m. and will continue intermittently to 3:40 p.m. Companies presenting in GreenTech Investor Sessions include:

For more information about companies presenting at GreenTech Investor Sessions at the 2018 BIO World Congress, please visit

Also, new at the 2018 BIO World Congress are company and technical presentations, taking place throughout the conference. More than 50 companies will be sharing their story, pipelines and objectives with BIO World Congress attendees in the education hall of the Pennsylvania Convention Center. For more information and to view a list of all presenting companies, visit

All programs and sessions at the 2018 BIO World Congress on Industrial Biotechnology are open to members of the media. Complimentary media registration is available to editors and reporters working full time for print, broadcast or web publications with valid press credentials.

For more information on the conference, please visit For assistance, please contact

Discover More
Washington, DC (November 20, 2020) – Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the Trump administration moved forward with its threat to impose…
"What a historic election for our country! For the first time in 120 years, American voter participation shattered many turnout records.    "At BIO we undertook an effort to mobilize and activate voters in our industry with Biotech Votes…
The Biotechnology Innovation Organization (BIO) today announced a new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness to changing political headwinds. Announcing the new vision, mission and…